FDA.reportPublic FDA data

NDC 0121-0747-10 - Sucralfate

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
0121-0747
Requested NDC
0121-0747-10
Package NDCs from labels
0121-0747-10, 0121-0747-00, 0121-0747-30, 0121-0747-50, 0121-0747-40
Manufacturer
Pharmaceutical Associates, Inc. | Actavis Laboratories UT, Inc.
Effective date
2023-06-20
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Sucralfate Oral SuspensionPharmaceutical Associates, Inc. | Actavis Laboratories UT, Inc.2023-06-20HUMAN PRESCRIPTION DRUG LABEL
Sucralfate - Cardinal Health 107, LLCCardinal Health 107, LLC2022-12-01HUMAN PRESCRIPTION DRUG LABEL
National Council for Prescription Drug Programs indexing - billing unitNational Council for Prescription Drug Programs2012-07-24Indexing - Billing Unit

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0121-0747-00ML - Milliliter0121-07478d664c6f-0cd4-4ad3-b597-acece443e1f412020-07-13
0121-0747-10ML - Milliliter0121-07479b3bc58d-5d2f-4493-a74d-4dafe53b789912012-07-24
0121-0747-40ML - Milliliter0121-0747b5d0cbb0-d70f-4be2-974e-1303998fef9d12017-06-15

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
SucralfateACTIVE INGREDIENTXX73205DH5SUCRALFATE SUSPENSION [PHARMACEUTICAL ASSOCIATES, INC.]2
SucralfateACTIVE MOIETYXX73205DH5SUCRALFATE SUSPENSION [PHARMACEUTICAL ASSOCIATES, INC.]2
SORBITOLINACTIVE INGREDIENT506T60A25RSUCRALFATE SUSPENSION [PHARMACEUTICAL ASSOCIATES, INC.]2

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 27 · 535 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Leader Eye Drops Redness ReliefGLYCERIN, NAPHAZOLINE HYDROCHLORIDECardinal Healthaee4bbe2-4f11-4c54-be8b-df48b3ba4f3a2026-09-09WarningsExact identifier
unii: PDC6A3C0OX
HemorrhoidalGLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUMRite Aid Corporation407c78ca-6fee-4ed6-b61b-711ec049c86e2026-09-09WarningsExact identifier
unii: PDC6A3C0OX
Clear Eyes NighttimeGLYCERINPrestige Brands Holdings, Inc.af75e2f7-81dd-43e0-a390-b52bbfbebf622026-09-08WarningsExact identifier
unii: PDC6A3C0OX
HemorrhoidalGLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUMCVS Pharmacy3167c918-a7d3-46a1-a85b-64f9c22916f22026-09-04WarningsExact identifier
unii: PDC6A3C0OX
SucralfateSUCRALFATEPreferred Pharmaceuticals Inc.536b8c00-13ab-4397-a754-63a1c92bf8832026-09-02Adverse reactionsExact identifier
unii: XX73205DH5
SucralfateSUCRALFATEVistaPharm, LLCcbfbe146-5d42-4a55-9050-df2b5581487a2026-09-02Warnings, Adverse reactionsExact identifier
rxcui: 313123
unii: XX73205DH5
SucralfateSUCRALFATEPreferred Pharmaceuticals Inc.5ec71444-cc55-47bd-8abc-b3cfc3b47d8e2026-09-01Adverse reactionsExact identifier
unii: XX73205DH5
SucralfateSUCRALFATEChartwell RX, LLC37aee721-b9c7-4e6b-a1a1-e826d8541d6b2026-08-27Warnings, Adverse reactionsExact identifier
rxcui: 313123
unii: XX73205DH5
KUGIG ALOE FOAMING INTIMATE WASHINTIMATE CLEANSING FOAMHong Kong KangXing Centennial Management Limited59f4d398-1186-a168-e063-6294a90ab44b2026-08-26WarningsExact identifier
unii: 059QF0KO0R
Sterile WaterWATERREMEDYREPACK INC.5dd5d148-6e23-41de-bff5-551b2aea95982026-08-24Warnings, Adverse reactionsExact identifier
unii: 059QF0KO0R
Leader Dry Eye Relief Eye DropsGLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400CARDINAL HEALTH 110, LLC. DBA LEADER2ded4bda-b3c3-4521-8701-5c8446fd148b2026-08-17WarningsExact identifier
unii: PDC6A3C0OX
BM BM63 DROPSCEANOTHUS, KALI ARSEN, KALI MUR, SELENIUM, THALLIUM, WIESBADENBM Private Limited59006d82-610a-2e08-e063-6394a90af1ed2026-08-14WarningsExact identifier
unii: 059QF0KO0R
BM BM164 DROPSARUM TRYPH, CAUSTICUM, BALSAMUM PERU, HELONIAS DIO, ACID PHOS, GLYCERINUM, EQUISETUMBM Private Limited5902770f-eb01-d099-e063-6394a90ad3eb2026-08-14WarningsExact identifier
unii: PDC6A3C0OX
SucralfateSUCRALFATEZydus Lifesciences Limited882b7596-f62c-4be2-8f67-e64310718baa2026-08-08Adverse reactionsExact identifier
unii: XX73205DH5
SucralfateSUCRALFATEViona Pharmaceuticals Incc708201b-2618-4470-a3ff-8ecf04d6b3a02026-08-08Adverse reactionsExact identifier
unii: XX73205DH5
Sterile WaterWATERCardinal Health 107, LLC48d75a7c-8329-48a8-bea0-a8c144ddf6372026-08-07Warnings, Adverse reactionsExact identifier
unii: 059QF0KO0R
CVS GlycerinGLYCERIN SUPPOISITORYCVS Pharmacy, Incca6d13db-60e8-4fcc-b7b3-3eb280b8c4352026-08-04WarningsExact identifier
unii: PDC6A3C0OX
GarzulysINSULIN ASPART-FSANMeitheal Pharmaceuticals Inc.30c64769-d2f7-4604-ac9e-2a6bc09506c92026-07-31Warnings, Adverse reactionsExact identifier
unii: 059QF0KO0R
SucralfateSUCRALFATECardinal Health 107, LLC444a743a-4843-4b33-bad5-3dfc1fb2d0042026-07-29Adverse reactionsExact identifier
unii: XX73205DH5
DECONIMO ReconstitutionDECONIMO RECONSTITUTIONImage Amazon LLC57ab9b1c-9a18-3786-e063-6394a90a2c632026-07-28WarningsExact identifier
unii: 059QF0KO0R

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.